🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit

Recruitingn/aAges any - anyAllCentre Hospitalier Universitaire de Besancon
NCT03934112 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria. These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies. It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: * Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered * Patient admitted between 1st January 2012 to 31st December 2017
💊

What it tests

  • Not listed
📍

Where

1 site
CHU de Besançon
Besançon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy